EVALUATION OF AN INSTITUTIONAL FIXED-DOSE 4-FACTOR PCC PROTOCOL

被引：0
|
作者：
Housley, Cora [1 ]
Trujillo, Toby [2 ]
Kiser, Tyree [3 ]
Van Matre, Edward [4 ]
MacLaren, Robert
Fish, Douglas
Reynolds, Paul [5 ]
Mueller, Scott
机构：
[1] Univ Kansas, Sch Pharm, Lawrence, KS 66045 USA
[2] Univ Colorado Denver, Aurora, CO USA
[3] Univ Colorado, Anschutz Med Campus, Aurora, CO USA
[4] Univ Colorado, Sch Pharm, Aurora, CO USA
[5] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA
来源：
CRITICAL CARE MEDICINE | 2019年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
903
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Evaluation of rifampicin bioequivalence in fixed-dose combinations using the WHO/IUATLD recommended protocol
    Panchagnula, R
    Agrawal, S
    Kaur, KJ
    Singh, I
    Kaul, CL
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2000, 4 (12) : 1169 - 1172
  • [32] 4-FACTOR PCC DOSING FOR URGENT ANTICOAGULATION REVERSAL IN PATIENTS WITH OBESITY
    Etter, Elaina
    Lindsey, Lindsey
    Curry, Marjorie
    Morrison, Christopher
    Chester, Katleen
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 316 - 316
  • [33] Statistical evaluation of the revised fixed-dose procedure
    Stallard, N
    Whitehead, A
    Ridgway, P
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2002, 21 (04) : 183 - 196
  • [34] Fixed dose 4-factor prothrombin complex concentrate for the emergent reversal of warfarin: a retrospective analysis
    Astrup, Greta
    Sarangarm, Preeyaporn
    Burnett, Allison
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (02) : 300 - 305
  • [35] IMPACT OF APPROPRIATE USE OF 4-FACTOR PCC ON BLOOD PRODUCT ADMINISTRATION
    Zimmerman, Lisa Hall
    Borden, Jennifer
    Faris, Janie
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 461 - 461
  • [36] Fixed dose 4-factor prothrombin complex concentrate for the emergent reversal of warfarin: a retrospective analysis
    Greta Astrup
    Preeyaporn Sarangarm
    Allison Burnett
    Journal of Thrombosis and Thrombolysis, 2018, 45 : 300 - 305
  • [37] Multi-centered evaluation of a novel fixed-dose four-factor prothrombin complex concentrate protocol for warfarin reversal
    Dietrich, Scott K.
    Mixon, Mark
    Holowatyj, Michael
    Werth, Josh C.
    Delgado, Stephanie A.
    Mascolo, Nicole E.
    Meister, Erin R.
    Zoucha, Shane M.
    Trujillo, Toby C.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2020, 38 (10): : 2096 - 2100
  • [38] COMPARISON OF WEIGHT-BASED AND FIXED-DOSE 4F-PCC FOR VITAMIN K ANTAGONIST REVERSAL
    Milkovits, Ashley
    McAllister, Kelly
    Sugrue, David
    Faris, Jane
    Schad, Jessica
    CRITICAL CARE MEDICINE, 2020, 48
  • [39] Weight-Based Dosing Versus a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate in Obese Patients Requiring Vitamin K Antagonist Reversal
    Elsamadisi, Pansy
    Cepeda, Mark A. G.
    Yankama, Tuyen
    Wong, Adrian
    Tran, Qua
    Eche, Ifeoma Mary
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (03) : 355 - 361
  • [40] Weight-Based Dosing Versus a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate in Obese Patients Requiring Vitamin K Antagonist Reversal
    Pansy Elsamadisi
    Mark A. G. Cepeda
    Tuyen Yankama
    Adrian Wong
    Qua Tran
    Ifeoma Mary Eche
    American Journal of Cardiovascular Drugs, 2021, 21 : 355 - 361
12345